Literature DB >> 3813654

Active proliferation of telangiectases in skin of patients with progressive systemic sclerosis (PSS).

S Kazandjian, P Bruneval, J N Fiessinger, J P Camilleri, E Housset.   

Abstract

The labeling index of endothelial cells as measured by in vitro autoradiography with 3H-thymidine and the electron microscopic structure of microvessels were studied in telangiectases. The telangiectases of eight patients with progressive systemic sclerosis (PSS) were compared with the cherry angiomas of six healthy controls subjects. The ultrastructural features of telangiectases were similar in the two groups and were characteristic of capillaries and postcapillary venules of the dermis, with multilayering of the vascular basement membrane. However, a significant difference existed between these two groups in an autoradiographic study: in PSS telangiectases, the average labeling index was 5.9%, whereas in cherry angiomas it was around 0.8%. Thus, the telangiectases in PSS are structures with accelerated endothelial proliferation, as are the other endothelial cells of microvessels anywhere in dermis in this disease. However, the great heterogeneity of the labeling index (varying from 0.5% to 27%) must be emphasized in telangiectases.

Entities:  

Mesh:

Year:  1986        PMID: 3813654     DOI: 10.1007/bf00404350

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  16 in total

1.  Ultrastructure of the human dermal microcirculation: the horizontal plexus of the papillary dermis.

Authors:  A Yen; I M Braverman
Journal:  J Invest Dermatol       Date:  1976-03       Impact factor: 8.551

2.  Proliferation and hyperplasia of vascular endothelium in human skin.

Authors:  G E Pierard; C Pierard-Franchimont; C M Lapiere
Journal:  Am J Dermatopathol       Date:  1985-10       Impact factor: 1.533

3.  [3H]Thymidine labeling of dermal endothelial cells in scleroderma.

Authors:  R Fleischmajer; J S Perlish
Journal:  J Invest Dermatol       Date:  1977-10       Impact factor: 8.551

4.  Fine structural capillary changes and basal lamina thickening in scleroderma (progressive systemic sclerosis) and Raynaud's disease.

Authors:  J P Camilleri; J N Fiessinger; C Debure; P Bruneval; V Tricottet; S Kazandjian; E Housset
Journal:  Pathol Res Pract       Date:  1984-01       Impact factor: 3.250

5.  The proliferation of capillary endothelial cells.

Authors:  I F Tannock; S Hayashi
Journal:  Cancer Res       Date:  1972-01       Impact factor: 12.701

6.  Cytotoxic activity of sera from scleroderma and other connective tissue diseases. Lack of cellular and disease specificity.

Authors:  W R Shanahan; J H Korn
Journal:  Arthritis Rheum       Date:  1982-12

7.  Skin capillary changes in early systemic scleroderma. Electron microscopy and "in vitro" autoradiography with tritiated thymidine.

Authors:  R Fleischmajer; J S Perlish; K V Shaw; D J Pirozzi
Journal:  Arch Dermatol       Date:  1976-11

Review 8.  Vascular disease in progressive systemic sclerosis (scleroderma).

Authors:  W L Norton; J M Nardo
Journal:  Ann Intern Med       Date:  1970-08       Impact factor: 25.391

9.  Endothelial cell renewal in skin of patients with progressive systemic sclerosis (PSS): an in vitro autoradiographic study.

Authors:  S Kazandjian; J N Fiessinger; J P Camilleri; J P Dadoune; E Housset
Journal:  Acta Derm Venereol       Date:  1982       Impact factor: 4.437

10.  Endothelial injury in scleroderma.

Authors:  M B Kahaleh; G K Sherer; E C LeRoy
Journal:  J Exp Med       Date:  1979-06-01       Impact factor: 14.307

View more
  3 in total

Review 1.  Cellular and molecular aspects of vascular dysfunction in systemic sclerosis.

Authors:  Maria Trojanowska
Journal:  Nat Rev Rheumatol       Date:  2010-06-29       Impact factor: 20.543

2.  Telangiectases in scleroderma: a potential clinical marker of pulmonary arterial hypertension.

Authors:  Ami A Shah; Fredrick M Wigley; Laura K Hummers
Journal:  J Rheumatol       Date:  2009-12-01       Impact factor: 4.666

Review 3.  Vascular disease in scleroderma.

Authors:  Fredrick M Wigley
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.